Daniel Kelsey named new AHRA CEO

AHRA has announced that Daniel Kelsey, MBA, CAE, is its newest CEO. Kelsey has more than 20 years of experience with nonprofit organizations working on strategic planning and business development. He previously served as deputy CEO for the American Association of Clinical Endocrinologists.

“As a veteran of the healthcare association world, I’m very excited to join AHRA, the preeminent organization for imaging leaders, who set and live up to high standards for quality care and innovation,” Kelsey said in a prepared statement. “All of my professional experience will enable me to enhance AHRA’s commitment to member success and education, advocacy, and certification. I look forward to upholding the AHRA’s strong priorities and financial soundness, while expanding its reach to increase the impact and awareness of the organization.”

“Dan’s strategic drive, distinguished career in the association management community, and passion for membership make him the perfect choice to lead AHRA and help shape the strategic focus and advocacy efforts of the next phase of its development,” Bill Algee, AHRA president, said in the same statement. “We’re thrilled to welcome Dan aboard.” 

AHRA's previous CEO, Ed Cronin, Jr., retired earlier this year after spending 14 years in the position. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.